Evidence of bacterial DNA presence in chorionic villi and amniotic fluid in the first and second trimester of pregnancy
Abstract
The sterile-womb dogma in uncomplicated pregnancy has been lively debated. Data regarding the in utero microbiome environment are based mainly on studies performed at the time of delivery. Aim: To determine whether human placenta and amniotic fluid are populated by a bacterial microbiota in the first and second trimesters of pregnancy. Materials & methods: We analyzed by next-generation sequencing method 24 and 29 samples from chorionic villus sampling (CVS) and amniocentesis (AC), respectively. The V3 region of the 16S rRNA gene was sequenced. Results: 37.5% of CVS and 14% of AC samples showed the presence of bacterial DNA. Conclusion: Our study suggests that bacterial DNA can be identified in the placenta and amniotic fluid during early prenatal life.
References
- 1. . Inflammation in pregnancy: its roles in reproductive physiology, obstetrical complications, and fetal injury. Nutr. Rev. 65(Suppl. 3), S194–S202 (2007).
- 2. . The placenta harbors a unique microbiome. Sci. Transl. Med. 6(237), 237ra65–237ra65 (2014).
- 3. . The preterm placental microbiome varies in association with excess maternal gestational weight gain. Am. J. Obstet. Gynecol. 212(5), 653.e1–653.e16 (2015).
- 4. The placental membrane microbiome is altered among subjects with spontaneous preterm birth with and without chorioamnionitis. Am. J. Obstet. Gynecol. 214(5), 627.e1–627.e16 (2016).
- 5. Visualization of microbes by 16S in situ hybridization in term and preterm placentas without intraamniotic infection. Am. J. Obstet. Gynecol. 221(2), 146.e1–146.e23 (2019).
- 6. Antenatal microbial colonization of mammalian gut. Reprod. Sci. 26(8), 1045–1053 (2019).
- 7. . Bifidobacterium and Lactobacillus DNA in the human placenta. Lett. Appl. Microbiol. 48(1), 8–12 (2009).
- 8. . Human gut colonisation may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid. Sci. Rep. 6(1), 1–13 (2016).
- 9. . A critical assessment of the ‘sterile womb’ and ‘in utero colonization’ hypotheses: implications for research on the pioneer infant microbiome. Microbiome 28;5(1), 48 (2017).
- 10. Bacterial DNA is present in the fetal intestine and overlaps with that in the placenta in mice. PLoS ONE 13(5), e0197439 (2018).
- 11. . Initial exploration of in utero microbial colonization. Nat. Med. 26(4), 469–470 (2020).
- 12. . Fusobacterium nucleatum induces premature and term stillbirths in pregnant mice: implication of oral bacteria in preterm birth. Infect. Immun. 72(4), 2272–2279 (2004).
- 13. . Uncultivated bacteria as etiologic agents of intra-amniotic inflammation leading to preterm birth. J. Clin. Microbiol. 47(1), 38–47 (2009).
- 14. Microbial prevalence, diversity and abundance in amniotic fluid during preterm labor: a molecular and culture-based investigation. PLoS ONE 3(8), e3056 (2008).
- 15. Bacteria and inflammatory cells in fetal membranes do not always cause preterm labor. Pediatr. Res. 57(3), 404–411 (2005).
- 16. . The prenatal gut microbiome: are we colonized with bacteria in utero? Pediatrs Obes. 12(Suppl. 1), 3–17 (2017).
- 17. Human placenta has no microbiome but can contain potential pathogens. Nature 572(7769), 329–334 (2019).
- 18. Comparison of placenta samples with contamination controls does not provide evidence for a distinct placenta microbiota. Microbiome 4(1), 29 (2016).
- 19. Lack of detection of a human placenta microbiome in samples from preterm and term deliveries. Microbiome 6(1), 196 (2018).
- 20. Enrichment of clinically relevant organisms in spontaneous preterm-delivered placentas and reagent contamination across all clinical groups in a large pregnancy cohort in the United Kingdom. Appl. Environ. Microbiol. 84(14), e00483-18 (2018).
- 21. Does the human placenta delivered at term have a microbiota? Results of cultivation, quantitative real-time PCR, 16S rRNA gene sequencing, and metagenomics. Am. J. Obstet. Gynecol. 220(3), 267.e1–267.e39 (2019).
- 22. Reagent and laboratory contamination can critically impact sequence-based microbiome analyses. BMC Biol. 12(1), 87 (2014).
- 23. Recognizing the reagent microbiome. Nat. Microbiol. 3(8), 851–853 (2018).
- 24. 26: profiling of microbiota in second trimester amniotic fluid reveals a distinctive community present in the mid trimester and predictive of the placental microbiome at parturition. Am. J. Obstet. Gynecol. 216(1), S18–S19 (2017).
- 25. . In vivo microbiome and associated immune markers: new insights into the pathogenesis of vaginal dysbiosis. Sci. Rep. 8(1), 2307 (2018).
- 26. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods. 7(5), 335–336 (2010).
- 27. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol. 37(8), 852–857 (2019).
- 28. . The effect of 16s rRNA region choice on bacterial community metabarcoding results. Sci. Data 6(1), 1–14 (2019).
- 29. . The vaginal microbiota and its association with human papillomavirus, Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium infections: a systematic review and meta-analysis. Clin Microbiol. Infect. 25(1), 35–47 (2019).
- 30. Modifications in vaginal microbiota and their influence on drug release: challenges and opportunities. Pharmaceutics. 11(5), 217 (2019).
- 31. Intestinal microbiota is influenced by gender and body mass index. PLoS ONE 11(5), e0154090 (2016).
- 32. . The rebirth of culture in microbiology through the example of culturomics to study human gut microbiota. Clin. Microbiol. Rev. 28(1), 237–264 (2015).
- 33. Amplicon sequencing provides more accurate microbiome information in healthy children compared to culturing. Commun. Biol. 2(1), 1–7 (2019).
- 34. Targeting the 16s rRNA gene for bacterial identification in complex mixed samples: comparative evaluation of second (illumina) and third (oxford nanopore technologies) generation sequencing technologies. Int. J. Mol. Sci. 21(1), 1–22 (2020).
- 35. . Endometrial microbes and microbiome: recent insights on the inflammatory and immune “players” of the human endometrium. Am. J. Reprod. Immunol. 80(6), e13065 (2018).
- 36. Prevalence of chronic endometritis in repeated unexplained implantation failure and the IVF success rate after antibiotic therapy. Hum. Reprod. 30(2), 323–330 (2015).
- 37. . Infection and stillbirth. Semin. Fetal Neonatal Med. 14(4), 182–189 (2009).
- 38. . The role of inflammation and infection in preterm birth. Semin Reprod Med. 25(1), 21–39 (2007).
- 39. Prevalence and diversity of microbes in the amniotic fluid, the fetal inflammatory response, and pregnancy outcome in women with preterm pre-labor rupture of membranes. Am. J. Reprod. Immunol. 64(1), 38–57 (2010).
- 40. Isolation of commensal bacteria from umbilical cord blood of healthy neonates born by cesarean section. Curr. Microbiol. 51(4), 270–274 (2005).
- 41. . A holobiont birth narrative: the epigenetic transmission of the human microbiome. Front. Genet. 5(AUG), 5–282 (2014).
- 42. . Placental vascular development and neonatal outcome. Semin Neonatol. 9(4), 255–263 (2004).
- 43. . Regulation of vascular growth and function in the human placenta. Reproduction. 138(6), 895–902 (2009).
- 44. Uteroplacental vascular development and placental function: an update. Int. J. Dev. Biol. 54(2–3), 355–365 (2010).
- 45. . A practical guide to the oral microbiome and its relation to health and disease. Oral Dis. 23(3), 276–286 (2017).
- 46. . Protecting the outside: biological tools to manipulate the skin microbiota. FEMS Microbiol Ecol. 96(6),
doi.org/10.1093/femsec/fiaa085 (2020). - 47. . Colonization of second-trimester placenta parenchyma. Am. J. Obstet. Gynecol. 199(1), 52.e1–52.e10 (2008).